Influence of cladribine alone and in combinaton with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia [9]

Leukemia and Lymphoma

Volumn 48, Issue 5, 2007, Pages 1042-1044

  Szmigielska Kapłon, Anna ^a   Jesionek Kupnicka, Dorota ^a   Góra Tybor, Joanna ^a   Błonski, Jerzy Z ^a   Lech Maranda, Ewa ^a   Kordek, Radzisław ^a   Kasznicki, Marek ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD34 ANTIGEN; CD5 ANTIGEN; CLADRIBINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; MITOXANTRONE;

ADULT; AGED; ANGIOGENESIS; BONE MARROW; BONE MARROW BIOPSY; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKEMIA REMISSION; MALE; MICROVASCULATURE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW CELLS; CLADRIBINE; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MICROCIRCULATION; MIDDLE AGED; MITOXANTRONE; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME;

EID: 34547483324     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701243455     Document Type: Letter

References (15)

1. Poon, R Tung-Ping, Fan, S. T. and Wong, J. (2001) Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol, 19, pp. 1207-1225.
2. Mangi, M. H. and Newland, A. C. (2000) Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol, 111, pp. 43-51.
3. Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E. and Thomas, D. (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 96, pp. 2240-2245.
4. Molica, S., Vacca, A., Ribatti, D., CuneoA, Cavazzini, F. and Levato, D. (2002) Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood, 100, pp. 3344-3351.
5. Góra-Tybor, J., Błonski, J. Z. and Robak, T. (2003) Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm, 12, pp. 167-171.
6. Molica, S., Vitelli, G., Levato, D., Gandolfo, G. M. and Liso, V. (1999) Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukemia. Br J Haematol, 107, pp. 605-610.
7. Kini, A. R., Kay, N. E. and Peterson, L. C. (2000) Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia, 14, pp. 1414-1418.
8. Cheson, B. D., Bennett, J. M., Grever, M., Kay, N., Keating, M. J., O'Brien, S. and Rai, K. R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood, 87, pp. 4990-4997.
9. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N. and Pasternack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, pp. 219-234.
10. Kay, N. E., Bone, N. D., Tschumper, R. C., Howell, K. H., Geyer, S. M. and Dewald, G. W. (2002) B-CLL cells are capable of synthesis and secretion of both pro- and antiangiogenic molecules. Leukemia, 16, pp. 911-919.
11. Wołowiec, D., Dybko, J., Wrobel, T., Urbaniak-Kujda, D., Jazwiec, B. and Tomaszewska-Toporska, B. (2006) Circulating sCD138 and some angiogenesis involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia. Mediators Inflamm, 3, p. 42394.
12. Wolowiec, D., Wozniak, Z., Potoczek, S., Ganczarski, G., Wrobel, T. and Kuliczkowski, K. (2004) Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia. Anal Qant Cytol Histol, 26:5, pp. 263-270.
13. Robak, T. (2006) Therapy of chronic lymphocytic leukemia with purine nucleoside analogues. Drugs Aging, 22, pp. 983-1012.
14. Molica, S., Vacca, A., Tucci, L. and Ribatti, D. (2005) Reversed bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. Hematologica/Hematol J, 90, pp. 698-699.
15. Gora-Tybor, J., Blonski, J. Z. and Robak, T. (2002) Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. Neoplasma, 49, pp. 145-148.